Latest Breaking News On - கீர்த்தி சதா - Page 1 : comparemela.com

Express News Service BENGALURU: The peak of the second wave of Covid-19 had left patients grappling for ICU beds and ventilators and many even losing their lives due to their non-availability in hospitals. Now, a simple blood test may be able to identify the risk status of a hospitalised Covid-19 patient. Metropolis Healthcare Ltd, a diagnostic service provider, has launched the blood test, called CoviRisk-TNBK (IVD approved flow cytometry-based lymphocyte subset assay, which estimates the T, B, and Natural Killer (NK) cells besides the CD4 and CD8 sub-populations of T-cells in peripheral blood) for cell-mediated response to SARS-CoV2 which can assist clinicians to identify the severity and prognosis within six hours.

Sanjay gohilChetana belagereKirti chadhaAffairs at metropolis healthcare ltdMetropolis healthcare ltdGroup headNews serviceHealthcare ltdNatural killerConsultant pathologistMetropolis healthcareFlow cytometryMedical affairsசஞ்சய் கோஹில்கீர்த்தி சதாபெருநகர சுகாதாரம் லிமிடெட்